Suppr超能文献

豚鼠巨白蛋白。血浆中活化的哈格曼因子的主要抑制剂,具有α2-巨球蛋白样性质。

Guinea pig macroalbumin. A major inhibitor of activated Hageman factor in plasma with an alpha 2-macroglobulin-like nature.

作者信息

Ishimatsu T, Yamamoto T, Kozono K, Kambara T

出版信息

Am J Pathol. 1984 Apr;115(1):57-69.

Abstract

A major inhibitor of the beta form of activated Hageman factor (beta-HFa) with an apparent molecular weight of 28,000, which was reported as a strong permeability factor (Yamamoto and Cochrane, Am J Pathol 1981, 105: 164-175), was purified from guinea pig plasma. When it was depleted in vitro, the plasma lost 71% of the total inhibitory activity toward beta-HFa. The inhibitor, termed "macroalbumin," with an apparent molecular weight of 720,000 and an apparent pI of 4.6, seemed to be an inhibitor similar to alpha 1- or alpha 2-macroglobulin of man and other mammalian species in physicochemical characteristics and in enzymologic properties. Though the inhibitory activity to beta-HFa was negligible in normal skin extract, a significant inhibitory activity appeared in extracts of permeability-enhanced skin sites which were induced by intradermal beta-HFa injection. The inhibitory activity that appeared was macroalbumin-dependent, with more than a 10-fold increase in the concentration. These results indicate the roles of macroalbumin as a negative feedback regulator in situ to the Hageman-factor-dependent pathway in a permeability enhancement system.

摘要

从豚鼠血浆中纯化出一种活化的哈格曼因子β型(β-HFa)的主要抑制剂,其表观分子量为28,000,据报道它是一种强效通透因子(山本和科克伦,《美国病理学杂志》1981年,105: 164 - 175)。当在体外将其去除时,血浆失去了对β-HFa总抑制活性的71%。这种抑制剂被称为“巨白蛋白”,表观分子量为720,000,表观pI为4.6,在物理化学特性和酶学性质方面似乎是一种类似于人类及其他哺乳动物物种的α1或α2巨球蛋白的抑制剂。尽管在正常皮肤提取物中对β-HFa的抑制活性可忽略不计,但在皮内注射β-HFa诱导的通透性增强皮肤部位的提取物中出现了显著的抑制活性。出现的抑制活性依赖于巨白蛋白,浓度增加了10倍以上。这些结果表明巨白蛋白在通透性增强系统中作为对哈格曼因子依赖性途径的原位负反馈调节因子的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7671/1900347/5d6aad7b1735/amjpathol00181-0068-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验